As its next big bet, Sana inks long-term lease for manufacturing site for next-gen cell therapies July 15, 2021
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors July 15, 2021
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment July 14, 2021
Devoted Health Announces Maine Office Expansion, Creating at Least 40 New Jobs in Cumberland County July 14, 2021
Castor, a clinical trial process company, raises $45M to create more human-centered research July 14, 2021
Prime Medicine – This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases July 13, 2021
Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain July 13, 2021
Stamford Health Chooses PatientPing’s Route Solution to Achieve E-Notifications CoP Compliance Under CMS’s Interoperability and Patient Access Rule July 13, 2021
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China July 13, 2021
Caribou Biosciences Announces Dosing of First Patient in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma July 12, 2021